#USA #Miami #FDA Clearance #SmartVertigo #VertigoDx

VertigoDx Achieves FDA Clearance for SmartVertigo® System

VertigoDx, an innovative player in the medical device industry, has recently secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its latest product, the SmartVertigo® Vestibular Assessment System. This revolutionary point-of-care diagnostic platform is specifically designed to facilitate the evaluation of vertigo, particularly focusing on conditions such as Benign Paroxysmal Positional Vertigo (BPPV).

A Breakthrough In Vertigo Diagnosis

Dizziness and vertigo can be deeply disconcerting experiences for patients, and traditional evaluation methods often fall short due to their complexity and cost. The SmartVertigo® system utilizes a cutting-edge combination of smartphone technology, a specialized light-occluding headset, and AI-driven software to efficiently capture and analyze nystagmus, the involuntary eye movements often associated with vertigo.

Dr. Paul Louis, CEO and Co-Founder of VertigoDx, emphasized the significance of their advanced approach. “BPPV is one of the most treatable causes of dizziness. The challenge has always been capturing the eye movement patterns without cumbersome equipment while also interpreting them accurately,” he stated. The SmartVertigo® system aims to eliminate these challenges, providing healthcare practitioners with an effective tool to deliver timely and accurate diagnoses.

Enhanced Diagnostic Capabilities

Traditionally, diagnosing BPPV involved using complex infrared video-oculography (VOG) systems, which are both high-cost and limited in their portability. Many healthcare practitioners lacked access to such cumbersome systems, leading to delays in patient care and unnecessary referrals.
The SmartVertigo® system transforms this landscape by introducing a portable, cable-free solution. Unlike conventional infrared devices that only provide black-and-white video, the SmartVertigo® captures full-color high-resolution video, allowing clinicians to see subtle details in eye movements that could be critical for an accurate diagnosis.

The system operates through a streamlined workflow that breaks down the diagnostic process into three key phases:
1. Capture: It records high-quality video of horizontal, vertical, and torsional nystagmus during standardized positional tests.
2. Classify: Leveraging AI technology developed in partnership with Florida Atlantic University, the software analyzes the captured eye movements and suggests the likely affected semicircular canal, aiding clinicians in their assessment.
3. Treat: The system provides recommended repositioning maneuvers, while maintaining physician discretion in decision-making.

Real-World Application and Effectiveness

The SmartVertigo® system is co-invented by brothers Trevor and Stephen Meyerowitz, with Trevor actively applying the technology in clinical settings. In his practice, he has engaged with over 1,200 patients, reflecting his firsthand knowledge of the system’s effectiveness. Trevor highlights the need for this technology, stating, “I built SmartVertigo® because I was frustrated with relying on what I thought I saw. Some eye movements are too subtle to capture with standard Frenzel goggles. The video replay feature allows me to capture the necessary nystagmus data with greater accuracy.”

The incorporation of AI into the diagnostic framework has not only enhanced Trevor's confidence in his assessments but also improved patient engagement. Sharing their eye movement data helps patients better understand their condition and treatment pathway, fostering improved communication and trust.

Future Outlook and Availability

Pre-orders for the SmartVertigo® system have already commenced, signaling a promising future for this groundbreaking technology. Interested parties can reach out to VertigoDx to reserve their system. With the SmartVertigo®, the bar for vestibular diagnostics is raised, promising to enhance clinical decision-making and patient outcomes across healthcare settings.

For more information on SmartVertigo®, potential customers can visit www.vertigodx.com.

About VertigoDx

VertigoDx is dedicated to making vestibular diagnostics accessible and efficient at points of patient care. With a commitment to innovative mobile technologies, they empower healthcare providers to capture and analyze objective nystagmus data effectively.